According to Genmab's latest financial reports the company's current EPS (TTM) is $1.01. In 2022 the company made an earnings per share (EPS) of $1.16 an increase over its 2021 EPS that were of $0.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.01 | -13.55% |
2022 | $1.16 | 62.07% |
2021 | $0.72 | -35.78% |
2020 | $1.12 | 119.14% |
2019 | $0.51 | 36.35% |
2018 | $0.37 | 29.83% |
2017 | $0.29 | 0.92% |
2016 | $0.29 | 47.69% |
2015 | $0.19 | 109.32% |
2014 | $0.09240 | 134.03% |
2013 | $0.03948 | -121.08% |
2012 | -$0.19 | -23.69% |
2011 | -$0.25 | 94.77% |
2010 | -$0.13 | -70.48% |
2009 | -$0.43 |